The Netherlands delivers new headquarters to EMA
The Netherlands has officially delivered the new headquarters to the European Medicines Agency (EMA). Minister Bruno Bruins (Health, Care and Sports) complimented all parties involved with this special achievement, because the new building has been built within a very short time frame. It helps EMA continuing carrying out their activities by assessing medicines without any interruption. The building is situated in the Zuidas area of Amsterdam.
Exactly two years after the announcement that EMAwould come to the Netherlands, its new building inZuidas, Amsterdam is finished. The new building was built in 18 months. The Netherlands did their utmost to avoid any interruption of the important work of the agency. The new premises has 1,300 workplaces and 19 conference rooms. Furthermore, it is sustainably designed and built. It has, for instance, a 60 meter high green wall filled with almost 53,000 plants. The new building also has a large conference room where public hearings for patients and healthcare professionals can be held. EMA brings annually 36,000 visitors to the Netherlands. It also attracts a lot of companies and it reinforces the Life Sciences & Health sector.
Minister Bruins: “It is a beautiful and important achievement that EMA will be able to move in this new building in time as promised. Built at a high pace and in a very short time frame. EMA must always continue its important work without hindrances by assessing the quality and safety of medicines in the interest of patients. I am proud of the cooperation between the various departments, the Corporate Government Real Estate Agency, the city of Amsterdam, the construction company (Dura Vermeer/Heijmans) and EMA. This all led to a fantastic building ready for the future.
Guido Rasi, Executive Director of EMA: “This is an important milestone and we congratulate the Dutch authorities who delivered this impressive building in less than 20 months. With our move to the final building, the Agency will finally be able to refocus fully on our important mission for public and animal health.”
Vytenis Andriukaitis, European Commissioner for Health and Food Safety: “I want to thank the Dutch authorities for taking on the challenge of building this permanent facility in record time. I also wholeheartedly thank all the EMA staff who went through some turbulence in the interest of public health. The importance of the work done by EMA cannot be underestimated.”
EMA and the Netherlands will use the weeks after the delivery to prepare the building to be ready for operation. EMA is currently temporarily housed in the Spark building in Amsterdam. The move to the new building will take place around Christmas. It will be coordinated and executed by the Netherlands. In January 2020 the move will be finished. From January 20, EMA will be fully operating from the new building.
Medicines for humans and animals
EMAis a decentralised agency of the European Union (EU). It fosters scientific excellence in the evaluation and supervision of medicines, for the benefit of public and animal health in EU.Its work is crucial for millions of citizens in Europe.